6-Month Follow-Up | Patients (n = 32) | P Value | |
---|---|---|---|
Treatment-Related Change (n = 20) | Tumor Progression (n =12) | ||
WHO grade | .71 | ||
Grade II | 3 | 2 | |
Grade III | 6 | 2 | |
Grade IV | 11 | 8 | |
No. of male patients | 12 (60%) | 6 (50%) | .59 |
Age (yr) | 61.5 (36–70) | 59.5 (21–69) | .71 |
Surgical extent (%) | .46 | ||
Biopsy or partial resection | 14 | 7 | |
Gross total resection | 6 | 5 | |
Postoperative standard radiation therapy or concurrent chemoradiation therapy | 19 | 11 | .55 |
↵a Data are expressed as the median and range for continuous variables. The χ2 test was used to test for differences in categoric variables between the 6-month stable and tumor-progression groups.